StarMed clinical evidence

Published studies on the StarMed range of CPAP and NIV respiratory hoods. For more information on the full StarMed range, including information sheets, videos and enquiries, please visit https://www.intersurgical.com/info/starmed

New Setting of Neurally Adjusted Ventilatory Assist during Noninvasive Ventilation through a Helmet [CaStar R Next]

Cammarota G, Longhini F, Perucca R, Ronco C, Colombo D, Messina A, Vaschetto R, Navalesi P.
Anesthesiology. 2016 Dec;125(6):1181-1189

Randomised trial of 15 patients undergoing three 30-minutes ventilation trials using two different helmets. The ventiltion modes were randomly applied: pneumatically triggered pressure support ventilation (PSP), neurally adjusted ventilatory assist (NAVA) and neurally controlled pressure support (PSN). The latter is a new proposed setting of the NAVA mode. Authors conclude that PSN improves comfort and patient-ventilator interactions in this scenario.

Link to abstract.

Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia

Brambilla AM, Aliberti S, Prina E, Nicoli F, Forno MD, Nava S, Ferrari G, Corradi F, Pelosi P, Bignamini A, Tarsia P, Cosentini R. Intensive Care Med. 2014 Jul;40(7):942-9

Multi-centre, randomised controlled trial across four Italian centres. Patients split into helmet CPAP and Venturi mask groups. Primary end point was percentage of patients meeting criteria for ETI. Authors conclude helmet CPAP reduces the risk of meeting ETI criteria in this scenario.

Link to abstract.

Prophylactic use of helmet CPAP after pulmonary lobectomy: a prospective randomized controlled study

Barbagallo M, Ortu A, Spadini E, Salvadori A, Ampollini L, Internullo E, Ziegler S, Fanelli G. Respir Care. 2012 Sep;57(9):1418-24

Randomised trial of 50 patients allocated to receive either continuous oxygen therapy or two cycles of helmet CPAP for 120 minutes. Results suggest that by the end of the second helmet treatment, patient's had a significantly higher PaO2/FiO2 but the improvement in oxygenation was not lasting. However, helmet CPAP was 'secure and well tolerated'.

Link to abstract.

Out-of-hospital helmet CPAP in acute respiratory failure reduces mortality: a study led by nurses

Garuti G, Bandiera G, Cattaruzza MS, Gelati L, Osborn JF, Toscani S, Confalonieri M, Lusuardi M.
Monaldi Arch Chest Dis. 2010 Dec;73(4):145-51

Prospective observational study investigating effect of CPAP prior to admission to emergency room, on reduction of endotracheal intubation, in-hospital mortality and length of stay. Results showed that mortality was reduced when helmet CPAP was applied both in the pre-hospital and in-hospital settings. Authors conclude that using CPAP by trained nurses is 'safe, reduces mortality and hospital length of stay'.

Link to abstract.

Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy

Squadrone V, Massaia M, Bruno B, Marmont F, Falda M, Bagna C, Bertone S, Filippini C, Slutsky AS, Vitolo U, Boccadoro M, Ranieri VM. Intensive Care Med. 2010 Oct; 36(10):1666-74

Study to determine effectiveness of early CPAP delivered in the ward to prevent occurrence of ALI requiring intensive care admission for mechanical ventilation. Primary outcomes measured were need of mechanical ventilation and intubation rate among patients requiring ICU admission.  Authors conclude early CPAP in this scenario prevents 'evolution to acute lung injury'.

Link to abstract.